Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Breast
Study Phase
Phase 2BPhase 3
Study Completion Date
March 2013
NCT00703326Uploaded 01-05-2017
Available for Download
PDS UID: Breast_EliLill_2008_168
A Multicenter, Multinational, Randomized, Double-Blind, Phase III Study of IMC-1121B Plus Docetaxel Versus Placebo Plus Docetaxel in Previously Untreated Patients With HER2-Negative, Unresectable, Locally-Recurrent or Metastatic Breast Cancer
Files:
PROTOCOLV8.0 Protocol CP12-0606_Redacted.pdf
CRFJVBC_SDTM_aCRF_redacted.pdf
DATA DICTIONARYJVBC_ADaM_dataset_specifications_redacted.pdf
DATA (COMPARATOR ARM)adam20161103.zip